Annual Working Capital
$21.09 M
-$11.82 M-35.93%
31 December 2023
Summary:
Corvus Pharmaceuticals annual working capital is currently $21.09 million, with the most recent change of -$11.82 million (-35.93%) on 31 December 2023. During the last 3 years, it has fallen by -$12.10 million (-36.46%). CRVS annual working capital is now -83.79% below its all-time high of $130.09 million, reached on 31 December 2016.CRVS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$3.48 M
-$38.41 M-109.98%
30 September 2024
Summary:
Corvus Pharmaceuticals quarterly working capital is currently -$3.48 million, with the most recent change of -$38.41 million (-109.98%) on 30 September 2024. Over the past year, it has dropped by -$29.28 million (-113.51%). CRVS quarterly working capital is now -102.31% below its all-time high of $150.69 million, reached on 31 March 2016.CRVS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.9% | -113.5% |
| 3 y3 years | -36.5% | -105.2% |
| 5 y5 years | -80.6% | -104.5% |
CRVS Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.8% | at low | -105.2% | at low |
| 5 y | 5 years | -80.6% | at low | -104.5% | at low |
| alltime | all time | -83.8% | +114.0% | -102.3% | at low |
Corvus Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$3.48 M(-110.0%) |
| June 2024 | - | $34.92 M(+116.5%) |
| Mar 2024 | - | $16.13 M(-23.5%) |
| Dec 2023 | $21.09 M(-35.9%) | $21.09 M(-18.3%) |
| Sept 2023 | - | $25.80 M(-14.2%) |
| June 2023 | - | $30.05 M(+10.2%) |
| Mar 2023 | - | $27.26 M(-17.2%) |
| Dec 2022 | $32.91 M(-46.6%) | $32.91 M(-11.7%) |
| Sept 2022 | - | $37.29 M(-23.5%) |
| June 2022 | - | $48.73 M(-11.6%) |
| Mar 2022 | - | $55.10 M(-10.6%) |
| Dec 2021 | $61.62 M(+85.7%) | $61.62 M(-8.6%) |
| Sept 2021 | - | $67.45 M(+18.8%) |
| June 2021 | - | $56.76 M(+3.4%) |
| Mar 2021 | - | $54.89 M(+65.4%) |
| Dec 2020 | $33.19 M(-52.0%) | $33.19 M(-18.1%) |
| Sept 2020 | - | $40.51 M(-17.3%) |
| June 2020 | - | $49.01 M(-15.7%) |
| Mar 2020 | - | $58.13 M(-15.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $69.12 M(-36.3%) | $69.12 M(-11.7%) |
| Sept 2019 | - | $78.31 M(-10.4%) |
| June 2019 | - | $87.44 M(-11.1%) |
| Mar 2019 | - | $98.37 M(-9.4%) |
| Dec 2018 | $108.56 M(+32.0%) | $108.56 M(-7.0%) |
| Sept 2018 | - | $116.78 M(-6.3%) |
| June 2018 | - | $124.65 M(-7.4%) |
| Mar 2018 | - | $134.56 M(+63.6%) |
| Dec 2017 | $82.27 M(-36.8%) | $82.27 M(-9.5%) |
| Sept 2017 | - | $90.89 M(-11.0%) |
| June 2017 | - | $102.12 M(-11.6%) |
| Mar 2017 | - | $115.54 M(-11.2%) |
| Dec 2016 | $130.09 M(+40.5%) | $130.09 M(-7.4%) |
| Sept 2016 | - | $140.44 M(-6.3%) |
| June 2016 | - | $149.89 M(-0.5%) |
| Mar 2016 | - | $150.69 M(+62.7%) |
| Dec 2015 | $92.59 M(+839.6%) | $92.59 M(-7.2%) |
| Sept 2015 | - | $99.81 M |
| Dec 2014 | $9.86 M | - |
FAQ
- What is Corvus Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual working capital year-on-year change?
- What is Corvus Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly working capital year-on-year change?
What is Corvus Pharmaceuticals annual working capital?
The current annual working capital of CRVS is $21.09 M
What is the all time high annual working capital for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual working capital is $130.09 M
What is Corvus Pharmaceuticals annual working capital year-on-year change?
Over the past year, CRVS annual working capital has changed by -$11.82 M (-35.93%)
What is Corvus Pharmaceuticals quarterly working capital?
The current quarterly working capital of CRVS is -$3.48 M
What is the all time high quarterly working capital for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly working capital is $150.69 M
What is Corvus Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, CRVS quarterly working capital has changed by -$29.28 M (-113.51%)